2cureX AB (publ) (FRA:2QE)

Market Cap	5.31M +511.3%
Revenue (ttm)	174.00K -49.7%
Net Income	-2.32M
EPS	-0.13
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	0.01 (7.25%)
Ex-Dividend Date	Jun 27, 2025

Volume	n/a
Average Volume	n/a
Open	0.2035
Previous Close	0.1668
Day's Range	0.2035 - 0.2035
52-Week Range	0.0432 - 0.4910
Beta	n/a
RSI	77.40
Earnings Date	May 21, 2026

About 2cureX AB

2cureX AB (publ) operates as a medical technology company in Europe. The company’s principal product is IndiTreat, an IVD test for the treatment of cancer by establishing 3D copies of the patient’s tumor and directly testing them against therapies. 2cureX AB (publ) was incorporated in 2006 and is based in Copenhagen, Denmark.

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2006
• Employees: 14
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 2QE

Financial Performance

In 2023, 2cureX AB's revenue was 2.95 million, a decrease of -12.53% compared to the previous year's 3.37 million. Losses were -32.52 million, 9.23% more than in 2022.

Financial numbers in SEK